Scarica l'app Stockscreener
46.00
1.25%
0.57
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SUPN Giù?
Forum
Previsione
Supernus Pharmaceuticals Inc Borsa (SUPN) Ultime notizie
Will Supernus Pharmaceuticals Inc. benefit from rising consumer demandPortfolio Return Summary & High Conviction Buy Zone Picks - خودرو بانک
Stock Analysis: Is Supernus Pharmaceuticals Inc. benefiting from interest rate changesJuly 2025 Outlook & Daily Chart Pattern Signal Reports - خودرو بانک
How to use a screener to detect Supernus Pharmaceuticals Inc. breakouts2025 Sector Review & AI Based Buy/Sell Signal Reports - Newser
Is Supernus Pharmaceuticals Inc. benefiting from interest rate changesEarnings Recap Summary & Precise Buy Zone Tips - خودرو بانک
Neurology biopharmas rebound on trial catalysts and Q2 gains - BioWorld MedTech
Can Supernus Pharmaceuticals Inc. expand into new markets2025 Price Targets & Free Community Supported Trade Ideas - خودرو بانک
Analyzing recovery setups for Supernus Pharmaceuticals Inc. investorsMarket Trend Review & Daily Stock Momentum Reports - Newser
Will Supernus Pharmaceuticals Inc. benefit from sector rotationJuly 2025 Gainers & AI Driven Stock Movement Reports - خودرو بانک
Analyzing net buyer seller activity in Supernus Pharmaceuticals Inc.July 2025 Sentiment & Weekly Breakout Stock Alerts - Newser
What’s the beta of Supernus Pharmaceuticals Inc. stockMarket Trend Report & Weekly Return Optimization Alerts - خودرو بانک
Has Supernus Pharmaceuticals Inc. found a price floorWeekly Profit Summary & Daily Chart Pattern Signals - Newser
How high can Supernus Pharmaceuticals Inc. stock goJuly 2025 PreEarnings & Real-Time Price Movement Reports - Newser
Supernus at Wells Fargo Conference: Strategic Growth in CNS By Investing.com - Investing.com Canada
Will Supernus Pharmaceuticals Inc. benefit from geopolitical trends2025 Investor Takeaways & Low Risk Growth Stock Ideas - خودرو بانک
Published on: 2025-09-04 06:09:28 - Newser
Supernus Pharmaceuticals Gets Retail Excited Over $795M Acquisition Plan For Sage Therapeutics - MSN
Predicting Supernus Pharmaceuticals Inc. trend using moving averagesMarket Risk Analysis & Long-Term Safe Investment Ideas - Newser
How sentiment analysis helps forecast Supernus Pharmaceuticals Inc.July 2025 Setups & High Yield Equity Trading Tips - Newser
What makes Supernus Pharmaceuticals Inc. stock price move sharplyJuly 2025 Reactions & Technical Entry and Exit Alerts - Newser
Will earnings trigger a reversal in Supernus Pharmaceuticals Inc.July 2025 Summary & Safe Capital Preservation Plans - Newser
Will Supernus Pharmaceuticals Inc. benefit from seasonalityMarket Sentiment Review & Reliable Entry Point Alerts - خودرو بانک
Real time breakdown of Supernus Pharmaceuticals Inc. stock performanceNew Guidance & Intraday High Probability Alerts - Newser
Risk vs reward if holding onto Supernus Pharmaceuticals Inc.July 2025 Pullbacks & High Conviction Buy Zone Alerts - Newser
Custom strategy builders for tracking Supernus Pharmaceuticals Inc.July 2025 Final Week & Technical Pattern Recognition Alerts - Newser
How to build a custom watchlist for Supernus Pharmaceuticals Inc.Weekly Stock Analysis & Capital Efficiency Focused Ideas - Newser
Sector ETF performance correlation with Supernus Pharmaceuticals Inc.2025 Price Action Summary & AI Driven Price Predictions - Newser
Candlestick signals on Supernus Pharmaceuticals Inc. stock today2025 Technical Patterns & Real-Time Buy Signal Notifications - Newser
Will Supernus Pharmaceuticals Inc. stock recover after earnings2025 Market Overview & Low Risk Profit Maximizing Plans - خودرو بانک
Supernus Pharmaceuticals stock hits 52-week high at $45.85 - Investing.com
Supernus Pharmaceuticals stock hits 52-week high at $45.85 By Investing.com - Investing.com UK
EV Market: What are Supernus Pharmaceuticals Inc.’s recent SEC filings showingPortfolio Return Report & Detailed Earnings Play Strategies - خودرو بانک
Sage Therapeutics, Inc. (SAGE) Bought by Supernus to Boost Neuropsychiatric Portfolio - Yahoo Finance
Using data filters to optimize entry into Supernus Pharmaceuticals Inc.Earnings Recap Report & Fast Entry Momentum Alerts - Newser
What hedge funds are buying Supernus Pharmaceuticals Inc.July 2025 Decliners & AI Driven Price Forecasts - خودرو بانک
Is Supernus Pharmaceuticals Inc. stock showing strong momentum2025 Biggest Moves & Daily Profit Maximizing Tips - خودرو بانک
What technical models suggest about Supernus Pharmaceuticals Inc.’s comebackPrice Action & Reliable Entry Point Trade Alerts - Newser
Market Outlook: What is the long term forecast for Supernus Pharmaceuticals Inc. stockBear Alert & Safe Entry Momentum Stock Tips - خودرو بانک
What are Supernus Pharmaceuticals Inc.’s earnings expectationsWeekly Risk Report & Stepwise Trade Execution Plans - خودرو بانک
Recovery Signals Appearing in Supernus Pharmaceuticals Inc. Charts getLinesFromResByArray error: size == 0 - 더경남뉴스
3.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):